Clinical Studies

Dexcom G5® Mobile CGM System - Sensor Accuracy in Pediatric Patients

You are here

Persistent use of a continuous glucose monitoring (CGM) system is tied to the sensor accuracy, particularly in the pediatric population who experience greater glycemic variability and wider glycemic excursions than adults. Clinical peformance data from the sensor used in the Dexcom G5 Mobile shows an overall MARD of 10%*–a level that approaches the accuracy of commonly used blood glucose meters.

*MARD is a statistical measure of accuracy accepted as the industry standard for measuring performance of glucose monitors; the lower the number, the better.

Source: Laffel, L. Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies. Diabetes Technol Ther. 2016;18(S2).

View the article.

More Clinical Studies

This paper reviews the features and available evidence supporting use of both real-time continuous glucose monitoring (rtCGM) and intermittent scanning CGM (isCGM), offering guidance for patient selection for each type of system. RtCGM systems (...

HypoDE study shows that Dexcom CGM use significantly reduces hypoglycemia in MDI patients.1 Background

Continuous glucose monitoring (CGM) clinical trials to date have largely excluded individuals with severe hypoglycemia (SH) or...

In hypoglycemia unaware patients, CGM provides the required information needed for enhanced decision making support to improve glycemic control and help eliminate severe hypoglycemia. In this observational study, severe hypoglycemia incidents...